High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis

Lancet

Volumn 364, Issue 9446, 2004, Pages 1690-1698

  Whitington, Peter F ^a   Hibbard, Judith U ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA FETOPROTEIN; ANTIOXIDANT; CHELATING AGENT; DEFEROXAMINE; FERRITIN; IMMUNOGLOBULIN; PROSTAGLANDIN E1; SELENIUM; TOCOFERSOLAN;

ARTICLE; BIRTH WEIGHT; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DONOR; DRUG EFFICACY; FEMALE; FETUS; FOLLOW UP; GESTATIONAL AGE; HEADACHE; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; INTERNATIONAL STANDARD UNIT; LIVER DYSFUNCTION; LIVER INJURY; LIVER TRANSPLANTATION; MALAISE; NEWBORN; NEWBORN DISEASE; PHYSICAL EXAMINATION; PREGNANCY; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; SIDEROSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 7644235252     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17356-X     Document Type: Article

References (41)

1. Knisely AS, Mieli-Vergani G, Whitington PF. Neonatal hemochromatosis. Gastroenterol Clin North Am. 32:2003;877-889
2. de Boissieu D, Knisely AS. Neonatal hemochromatosis. Suchy FJ, Sokol RJ, Balistreri WF. Liver disease in children. 2nd edn:2001;641-647 Lippincott, Williams and Wilkins, Philadelphia
3. Goldfischer S, Grotsky HW, Chang CH, et al. Idiopathic neonatal iron storage involving the liver, pancreas, heart, and endocrine and exocrine glands. Hepatology. 1:1981;58-64
4. Silver MM, Beverley DW, Valberg LS, Cutz E, Phillips MJ, Shaheed WA. Perinatal hemochromatosis: clinical, morphologic, and quantitative iron studies. Am J Pathol. 128:1987;538-554
5. Metzman R, Anand A, DeGiulio PA, Knisely AS. Hepatic disease associated with intrauterine parvovirus B19 infection in a newborn premature infant. J Pediatr Gastroenterol Nutr. 9:1989;112-114
6. Collins J, Goldfischer S. Perinatal hemochromatosis: one disease, several diseases or a spectrum? Hepatology. 12:1990;176-177
7. Ruchelli ED, Uri A, Dimmick JE, et al. Severe perinatal liver disease and Down syndrome: an apparent relationship. Hum Pathol. 22:1991;1274-1280
8. Taucher SC, Bentjerodt R, Hubner ME, Nazer J. Multiple malformations in neonatal hemochromatosis. Am J Med Genet. 50:1994;213-214
9. Shneider BL, Setchell KD, Whitington PF, Neilson KA, Suchy FJ. Delta 4-3-oxosteroid 5 beta-reductase deficiency causing neonatal liver failure and hemochromatosis. J Pediatr. 124:1994;234-238
10. Verloes A, Lombet J, Lambert Y, et al. Tricho-hepato-enteric syndrome: further delineation of a distinct syndrome with neonatal hemochromatosis phenotype, intractable diarrhea, and hair anomalies. Am J Med Genet. 68:1997;391-395
11. Witzleben CL, Uri A. Perinatal hemochromatosis: entity or end result? Hum Pathol. 20:1989;335-340
12. Hoogstraten J, de Sa DJ, Knisely AS. Fetal liver disease may precede extrahepatic siderosis in neonatal hemochromatosis. Gastroenterology. 98:1990;1699-1701
13. Kelly AL, Lunt PW, Rodrigues F, et al. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet. 38:2001;599-610
14. Cox TM, Halsall DJ. Hemochromatosis: neonatal and young subjects. Blood Cells Mol Dis. 29:2002;411-417
15. Ferrell L, Schmidt K, Sheffield V, Packman S. Neonatal hemochromatosis: genetic counseling based on retrospective pathologic diagnosis. Am J Med Genet. 44:1992;429-433
16. Shneider BL. Genetic counseling in neonatal hemochromatosis. J Pediatr Gastroenterol Nutr. 34:2002;328
17. Schoenlebe J, Buyon JP, Zitelli BJ, Friedman D, Greco MA, Knisely AS. Neonatal hemochromatosis associated with maternal autoantibodies against Ro/SS-A and La/SS-B ribonucleoproteins. Am J Dis Child. 147:1993;1072-1075
18. Kaplan C, Forestier F, Daffos F, Tchernia G, Waters A. Management of fetal and neonatal alloimmune thrombocytopenia. Transfus Med Rev. 10:1996;233-240
19. Margulies M, Voto LS. High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis? Obstet Gynecol. 77:1991;804-806
20. Margulies M, Voto LS, Mathet E. High-dose intravenous IgG for the treatment of severe rhesus alloimmunization. Vox Sang. 61:1991;181-189
21. Berlin G, Selbing A, Ryden G. Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin. Lancet. 1:1985;1153
22. Burks AW, Sampson HA, Buckley RH. Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia: detection of IgE antibodies to IgA. N Engl J Med. 314:1986;560-564
23. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med. 345:2001;747-755
24. Obiekwe BC, Malek N, Kitau MJ, Chard T. Maternal and fetal alphafetoprotein (AFP) levels at term: relation to sex, weight and gestation of the infant. Acta Obstet Gynecol Scand. 64:1985;251-253
25. Gitlin D. Normal biology of alpha-fetoprotein. Ann N Y Acad Sci. 259:1975;7-16
26. Allen K, Whitington PF. Evaluation of liver function. Polin R, Fox W. Fetal and neonatal physiology. 2nd edn:1998;1530-1552 WB Saunders, Philadelphia
27. Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med. 129:1998;925-931
28. Shamieh I, Kibort PK, Suchy FJ, Freese DK. Antioxidant therapy for neonatal iron storage disease (NISD). Pediatr Res 1993; 33: 109A (abstr).
29. Branch DW, Porter TF, Paidas MJ, Belfort MA, Gonik B. Obstetric uses of intravenous immunoglobulin: successes, failures, and promises J Allergy Clin Immunol 2001; 108 (suppl): S133-38.
30. Flynn DM, Mohan N, McKiernan P, et al. Progress in treatment and outcome for children with neonatal haemochromatosis. Arch Dis Child Fetal Neonatal Ed. 88:2003;F124-127
31. Shneider BL. Neonatal liver failure. Curr Opin Pediatr. 8:1996;495-501
32. Sigurdsson L, Reyes J, Kocoshis SA, Hansen TW, Rosh J, Knisely AS. Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr. 26:1998;85-89
33. Vohra P, Haller C, Emre S, et al. Neonatal hemochromatosis: the importance of early recognition of liver failure. J Pediatr. 136:2000;537-541
34. Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med. 346:2002;2053-2060
35. Riemersma S, Vincent A, Beeson D, et al. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J Clin Invest. 98:1996;2358-2363
36. Rothenberg SP, da Costa MP, Sequeira JM, et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med. 350:2004;134-142
37. da Costa M, Sequeira JM, Rothenberg SP, Weedon J. Antibodies to folate receptors impair embryogenesis and fetal development in the rat. Birth Defects Res Part A Clin Mol Teratol. 67:2003;837-847
38. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA. 98:2001;8780-8785
39. Sundaram SS, Alonso EM, Whitington PF. Liver transplantation in neonates. Liver Transpl. 9:2003;783-788
40. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med. 121:1994;259-262
41. Bagdasarian A, Tonetta S, Harel W, Mamidi R, Uemura Y. IVIG adverse reactions: potential role of cytokines and vasoactive substances. Vox Sang. 74:1998;74-82